Operating Lease, Right-of-Use Asset of Vanda Pharmaceuticals Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vanda Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Vanda Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,368,000, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vanda Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,368,000 -$1,648,000 -27% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $4,804,000 -$1,571,000 -25% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $5,208,000 -$1,534,000 -23% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,602,000 -$1,501,000 -21% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $6,016,000 -$1,412,000 -19% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,375,000 -$1,407,000 -18% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $6,742,000 -$1,355,000 -17% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $7,103,000 -$1,297,000 -15% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $7,428,000 -$834,000 -10% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $7,782,000 -$821,000 -9.5% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $8,097,000 -$848,000 -9.5% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $8,400,000 -$872,000 -9.4% 31 Dec 2022 10-K 08 Feb 2024 2023 FY
Q3 2022 $8,262,000 -$1,318,000 -14% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $8,603,000 -$1,295,000 -13% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $8,945,000 -$1,249,000 -12% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $9,272,000 -$1,187,000 -11% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q3 2021 $9,580,000 -$726,000 -7% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $9,898,000 -$703,000 -6.6% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $10,194,000 -$681,000 -6.3% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $10,459,000 -$721,000 -6.4% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $10,306,000 -$1,130,000 -9.9% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $10,601,000 -$1,117,000 -9.5% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $10,875,000 -$1,119,000 -9.3% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $11,180,000 +$11,180,000 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 $11,436,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $11,718,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $11,994,000 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 26 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.